This is a recording of the live session that was hosted on April 24, 2021.

The study of movement as a whole -THE KINETIC CHAIN- and the application of this analysis to examination and diagnosis of pathology is what makes physiatry so unique. The goal of the series is to revive understanding of the principles of kinetic chain analysis and return it to the forefront of one's practice. Each session will highlight an aspect of physical motion and review typical human movement as well as patterns seen in typical impairments. Faculty will provide practical tips on how they use their respective analyses in the evaluations of their patients. A robust Q&A session will accompany each event. 

During this session, faculty will discuss typical components of gait and its development. Faculty will explore how gait is altered in different impairments and how understanding the kinetic chain influences one’s assessment of specific injuries and their treatment options. Faculty will provide practical tips on how they use their respective analyses in the evaluations of their patients.

Learning Objectives
At the completion of this activity, participants will be able to:

• Recognize appropriate clinical management strategies for analysing gait impairments
• Explain all aspects of physical motion and can evaluate typical human movement as well as patterns seen in typical impairments
• Demonstrate the ability to examine and diagnosis the biomechanics of the kinetic chain
• Identify the various neurologic impairments that impact gait 

Agenda
10:00- 10:05: Introduction: John C. Cianca, MD 
10:05- 10:20: Normal Gait: D. Casey Kerrigan, MD
10:20-10:50: CNS Impairments: James K. Richardson, MD

• Hemiplegia
• NPH
• Cervical Myelopathy
• Parkinson’s

10:50- 11:20: Amputee Gait: David C. Morgenroth, MD
11:20- 11:50: Peripheral Neurological Impairments:  James K. Richardson, MD

• Diabetic (Distal Symmetric) Polyneuropathy
• Early Charcot-Marie-Tooth
• L5 Radiculopathy and S1 Radiculopathies (Bilateral)
• Radiation Plexopathies

11:50- 12:20: Running Gait: D. Casey Kerrigan, MD
12:20- 12:50: Runners Dystonia: Katharine E. Alter, MD
12:50- 1:00: Additional Q&A

Accreditation Statement

The American Academy of Physical Medicine and Rehabilitation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

 

Designation of Credit

The American Academy of Physical Medicine and Rehabilitation (AAPM&R) designates this enduring material for a maximum of 3 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. 

 

Financial Disclosures

In accordance with ACCME’s Standards for Integrity and Independence in Accredited Continuing Education, AAPM&R requires all individuals who are in a position to affect the strategic direction of AAPM&R and/or the content of an educational activity to disclose any financial relationships with an ineligible company within the last 24 months. The ACCME defines an “ineligible company” as any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The ACCME does not consider providers of clinical service directly to patients to be an ineligible company. Disclosures are made in written form prior to the start of the educational activity and any potential conflicts of interest that exist are resolved prior to the start of the activity through AAPM&R’s Conflict of Interest Disclosure and Resolution Policy Process. Individuals in a position to control content and their disclosed financial relationships are listed below.

 

Moderator

John C. Cianca, MD:  Ownership or partnership with Musculoskeletal Ultrasound Consultants, LLC.

 

Faculty

Katharine E. Alter, MD: Disclosed no relevant financial relationships.

D. Casey Kerrigan, MD: Ownership of OESH Shoes

David C. Morgenroth, MD: Disclosed no relevant financial relationships.

James K. Richardson, MD: Disclosed no relevant financial relationships.

 

AAPM&R Medical Education Committee

John C. Cianca, MD: Ownership or partnership with Musculoskeletal Ultrasound Consultants, LLC.

Karen P. Barr, MD: Disclosed no relevant financial relationships.

Anna-Christina Bevelaqua, MD: Disclosed no relevant financial relationships.

Rachel A. Brakke Holman, MD: Disclosed no relevant financial relationships.

Joseph E. Burris, MD: Serves on the Speakers Bureau for, and received clinical research grants from Allergan.

David S. Cheng, MD: Disclosed no relevant financial relationships.

Theresa A. Gillis, MD: Disclosed no relevant financial relationships.

Kevin N. Hakimi, MD: Disclosed no relevant financial relationships.

Rita G. Hamilton, DO: Disclosed no relevant financial relationships.

Scott E. Klass, MD, MS, ATCR: Disclosed no relevant financial relationships.

Chaitanya R. Konda, DO: Disclosed no relevant financial relationships.

Sam Mayer, MD: Royalties from Demos Medical Publishing.

Ameet S. Nagpal, MD MS MEd: Disclosed no relevant financial relationships.

Sunil Sabharwal, MD: Royalities from Demos Publishing; board member, American Board of Physical Medicine and Rehabilitation.

 

AAPM&R CME Committee

Karen P. Barr, MD: Disclosed no relevant financial relationships.

Cherry C. Junn, MD: Disclosed no relevant financial relationships.

Sheryl R. Levin, MD: Disclosed no relevant financial relationships.

Kentaro Onishi, DO: Disclosed no relevant financial relationships.

Evan R. Peck, MD: Disclosed no relevant financial relationships.

Cynthia G. Pineda, MD: Disclosed no relevant financial relationships.

Patricia T. Tan, MD: Disclosed no relevant financial relationships.

Brionn K. Tonkin, MD: Disclosed no relevant financial relationships.

Kristin A. Wong, MD: Disclosed no relevant financial relationships.

 

No other planners, faculty or individuals in control of content disclosed any financial relationships. Through the planning process, all relevant financial relationships have been mitigated.

 

FDA Disclosures

All faculty members for this activity have disclosed they do not intend to discuss or demonstrate any pharmaceutical or medical device for which FDA clearance has not been approved.